Cite
HARVARD Citation
Indini, A. et al. (2021). Adjuvant pembrolizumab for melanoma: update from the EORTC 1325-MG/KEYNOTE-054 trial. Lancet oncology. 22 (5), pp. 573-575. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Indini, A. et al. (2021). Adjuvant pembrolizumab for melanoma: update from the EORTC 1325-MG/KEYNOTE-054 trial. Lancet oncology. 22 (5), pp. 573-575. [Online].